Neoadjuvant Osimertinib and Surgically Resectable EGFR Targeted Therapies in Lung Cancer 2023
#############################
Video Source: www.youtube.com/watch?v=IKDDEszIRzc
Leading oncologists come together in this recorded live event to discuss targeted therapy options for patients with lung cancer. This includes a Q A with the audience and a presentation by a patient advocate, Ivy Elkins. • In this video, Dr. Isabel Preeshagul discusses the NEOS Trial, which tested neoadjuvant Osimertinib. • For more, please visit http://cancerGRACE.org/. • To join the conversation, visit https://cancergrace.org/forum. • BenSound File Name: Sweet (BenSound.com) • BenSound License #: DSSHUIYGV4VQCETM • Thank you to our sponsors: #Takeda #Janssen #Lilly #Genentech #Mirati #ExactSciences #BMS #GEHealthcare.
#############################